Welcome to our open innovation workspace where academic groups and startups developing ATMPs and medical devices are getting ready for clinical manufacturing.
“We hope to replace the insulin syringe with an innovative method and aim to bring a combination of an implant and cell therapy to the market for people with severe type I diabetes. Medace’s role is to facilitate logistics, clean rooms and quality systems.”
Aart van ApeldoornAssistant Professor Maastricht University / RegMed XB
“We are excited to setup our ATMP manufacturing at the Medace facilities. Their innovative business model which reduces risks and large investment suits InoCells best . Medace’s products and services such as lab facilities, GMP-ready clean rooms, quality management & regulatory support and its network with key partners, enables InoCells to reduce its time to market. InoCells is looking forward to a long-term collaboration with Medace.”
Mohammad Mehdi AkhondiManaging Director InoCells
“We are very excited to work with Medace, grow the company and have an impact on the Brightlands Maastricht Health Campus!”
Cyrille DepondtCEO Dutch Screening Group (DSG)
“For us the facilities and services Medace has to offer came just at the right time. We are quickly expanding, and this gives us the flexibility to continue today while preparing tomorrow.”
Peter VerstrateCOO Mosa Meat
“We look forward to working together with Medace, building a mutually beneficial relationship in order to advance medical device and ATMP developments in Europe.”
Sarah TsurkanFounder TissueGuard GmbH
“We are very much aware of the importance of quality in an ever changing medical device regulatory landscape. However, as hands-on entrepreneurs at ArchiMEDes, we also recognize where to seek collaboration. We are happy with Medace’s help in setting up our quality and regulatory strategy for our Archie.”
Nele Valkeneers and Richard HoubenCo-owners ArchiMEDes
“It’s great to see how the extraordinary collaborations we are advocates of – uniting researchers and entrepreneurs from all background and disciplines - have become a matter of course at Medace.”
Emiel StaringManaging Director Chemelot Institute for Science and Technology (InSciTe)
“We have recently signed a number of very large contracts and need to scale up. Medace has the necessary knowledge and experience and is therefore the right partner for Medprotex to set up our quality systems and to guarantee our future quality levels. We look forward to a successful collaboration!”
Nikolaj Boogaard and Cyrille DepondCo-founders Medprotex
“The Medace facility offers us a nice way to integrate the manufacturing into our fast growing company while minimizing the risk and resources of running such a facility ourselves.”
John MaruggCEO Corporis Medical
“We are excited to announce that we have accomplished a major milestone by installing the Obruza Beta system at Medace.”
Tanner CardenCEO Nestegg Biotech
“The facilities and expertise at Medace are great, the communication lines are short and there is a high degree of flexibility. This makes Medace an ideal partner for us at this stage of our development program.”
Ward van BuulCEO JointSphere
“At PL BioScience, we highly value the cooperation with Medace. The innovative and inspiring work environment gives us the opportunity to enhance the development of tomorrow's cell culture tools. That perfectly matches our mission to promote an animal-free future of cell culture solutions.”
Hatim HemedaCEO and founder PL BioScience GmbH
“In the development of our equipment access to a well equipped laboratory with the necessary consumables and reagents is key. Through the flexible, plug and play model at Medace we can make use of the facilities when we need them without having to making large investments ourself upfront. This helps us to take the necessary steps and remove barriers which we would normal come across when investing in such facilities ourselves.”
Hugo NikkelBusiness Developer Next Generation Sensors
“Medace helps us to accelerate in a flexible and cost effective way with the pre-clinical tests of our product through the usage of their advanced Research and Development facilities. This allows us to focus on the test results without having to make large capital expenses. We look forward to the intense collaboration and to learning from these qualified professionals.”
Jan HunikCEO Atro Medical